Webinar: Measles: An Overview of a Re-Emerging Disease

This one-hour webinar will provide an overview of the current outbreaks of measles in the United States, as well as the clinical presentation, treatment and prevention of measles.  Presenters will also cover the role of healthcare providers, state, and local health departments in the recognition, reporting, investigation, and appropriate laboratory testing for measles cases.

Objectives for Webinar: 

By the end of this webinar, participants will be able to:

• Describe the clinical presentation of measles;
• Understand treatment options and prevention methods for measles;
• Summarize the reporting and investigation for suspect measles cases; and
• Identify measles cases with the appropriate laboratory testing.

Speakers:

• Dr. Kathryn Moffett, Professor of Pediatrics; Assistant Dean, Faculty Personnel & Faculty Services; Division Chief, Pediatric Infectious Diseases; Director, Cystic Fibrosis & Therapeutics Development Centers.
• Dr. Stacy Tressler, Vaccine-Preventable Disease Epidemiologist, West Virginia Bureau for Public Health

Webinar Materials:

Dr. Moffett Presentation Slides

Dr. Tressler Measles 2024 – A Public Health Perspective_

Project Firstline Measles Document

COCA Now – Stay Alert for Measles

WV DIDE Measles Protocol

Measles Resources:

WV HAN 222 Measles Health Alert 4.22.24

CDC Measles Resource Page

CDC Pink Book Measles

Diagnosing Measles in a Pediatric Setting Webinar

CDC COCA Call: Measles (August 2023)

To receive CEUs for viewing the webinar, please complete the webinar evaluation here by May 24, 2024.

Continuing Education:

An application for 1.0 hours of continuing education for Nursing, Pharmacy, and Physicians has been approved for this event.

 

In support of improving patient care, this activity has been planned and implemented by WV Immunization Network , The Center for Rural Health Development and CAMC Institute for Academic Medicine. CAMC Institute for Academic Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Physicians-.  The CAMC Institute for Academic Medicine designates this live activity for a maximum of 1 hour for AMA PRA Category I Credit(s)™ . Physicians should only claim credit commensurate with the extent of their participation in the activity.

 

Nurses The CAMC Institute for Academic Medicine is an approved provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. This offering has been approved for 1 contact hour (JA0026-26-24-630)

 

Pharmacy – The CAMC Institute for Academic Medicine is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  To receive credit, participants must complete the sign-in sheet, attend each session and complete an evaluation. ACPE credits will be posted online to the CPE Monitor within six (6) weeks following the activity. This knowledge- based activity provides 10.5 contact hours (JA0006133-9999-24-032-L01-P)

DISCLOSURE AND MITIGATION

The CAMC Institute for Academic Medicine and WV Immunization Network, The Center for Rural Health Development control the content and production of this CE activity and attempt to ensure the presentation of balanced, objective information. In accordance with the Standards for Integrity and Independence in Accredited Continuing Education established by the ACCME, faculty, abstract reviewers, paper presenters/authors, planning committee members, staff and any others involved in planning the educational content must disclose any relationship they or their co-authors have with ineligible companies which may be related to their content. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 24 months that create a conflict of interest.

All presenters, planning committee and faculty have declared no financial interest with an ineligible company for this educational activity.